Highlights of the 16th Japan Bioanalysis Forum symposium
The 16th Japan Bioanalysis Forum (JBF) Symposium was held from March 3 to 5, 2025, at the Himeji Culture and Convention Center (Arcrea Himeji). The theme for the symposium was 'Bioanalyst Network: Spread and Circulation of Knowledge.' This theme symbolizes our commitment, based on the principle at the JBF foundation to provide a platform for discussion and interaction among bioanalysts in academia, industry, and government. It aims to restore the interaction among bioanalysts that has diminished during the Coronavirus disease 2019 (COVID-19) pandemic, and to discuss and share knowledge about rapidly evolving scientific technologies and the extensive insights of bioanalysis under regulatory. The symposium discussed a wide range of topics, including the latest mass spectrometric techniques, immunogenicity assessment, antibody - drug conjugate evaluation, biomarkers, ICH-M10, ICH-S12, data integrity, reliability assurance, and the interactive discussion program 'iDG,' inviting domestic and overseas experts. Approximately 400 attendees from various fields, including pharmaceutical companies, contract research organizations (CROs), academia, and regulators, gathered in person.
Authors
- Kento Yasui
- Yukihiro Otsuka
- Yoshihiro Nakase
- Makoto Takahashi (ORCID: https://orcid.org/0000-0003-3900-3973)
- Masayoshi Mizuochi
- Takashi Miyayama
- Chie Fukunaga
- Ryosuke Ide
- Noriyuki Koyama (ORCID: https://orcid.org/0000-0002-7509-6583)
- Hisanori Hara
- Eiichi Shimada
- Tsubasa Ibushi
- Makoto Niwa (ORCID: https://orcid.org/0000-0002-2355-1222)
- Yuki Takamatsu (ORCID: https://orcid.org/0009-0005-9552-1988)
- Masanori Nagata
- Tsuyoshi Kawahara
- Naohito Yamada
- H Kurisu
- Hideki Harada
- Takeshi Okuzono
- Ken-ichi Yamamoto
- Yohei Ohashi
- Tomofumi Ohyama
- Makoto Yamazaki
- Tomohiro Oka
- Hiroyuki Shimizu
Institutions
- Otsuka (Japan) (JP)
- Kyorin University (JP)
- Toray (United States) (US)
- Daiichi Sankyo (United Kingdom) (GB)
- Astellas Pharma (United Kingdom) (GB)
- LTT Bio-Pharma (Japan) (JP)
- Japan Tobacco (Japan) (JP)
- Chugai Pharma (United States) (US)
- Ono Pharmaceutical (Japan) (JP)
- Institute of Life Sciences (IN)
- Sekisui Medical (Japan) (JP)
- Shin Nippon Biomedical Laboratories (United States) (US)
- Otsuka Pharmaceutical (Spain) (ES)
- Pfizer (Japan) (JP)
- Mitsubishi Tanabe Pharma Corporation
- Takeda (Japan) (JP)
- Shimadzu (Japan) (JP)
Publication Details
- Journal
- Bioanalysis
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1080/17576180.2026.2613122
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00